Greater Cannabis Company (GCAN) Common Equity (2017 - 2022)
Greater Cannabis Company's Common Equity history spans 6 years, with the latest figure at -$561429.0 for Q3 2022.
- For Q3 2022, Common Equity fell 105.85% year-over-year to -$561429.0; the TTM value through Sep 2022 reached -$561429.0, down 105.85%, while the annual FY2021 figure was -$469062.0, 67.65% down from the prior year.
- Common Equity reached -$561429.0 in Q3 2022 per GCAN's latest filing, up from -$641653.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of $100779.0 in Q2 2018 to a low of -$2.4 million in Q1 2020.
- Average Common Equity over 5 years is -$613760.9, with a median of -$561429.0 recorded in 2022.
- Peak YoY movement for Common Equity: plummeted 729.12% in 2019, then surged 91.68% in 2021.
- A 5-year view of Common Equity shows it stood at -$563786.0 in 2018, then tumbled by 174.33% to -$1.5 million in 2019, then skyrocketed by 81.91% to -$279788.0 in 2020, then crashed by 67.65% to -$469062.0 in 2021, then fell by 19.69% to -$561429.0 in 2022.
- Per Business Quant, the three most recent readings for GCAN's Common Equity are -$561429.0 (Q3 2022), -$641653.0 (Q2 2022), and -$616748.0 (Q1 2022).